Thomas J van Rijssen
4PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Feb 12, 2026
Long-term follow-up of chronic central serous chorioretinopathy patients receiving oral eplerenone and half-dose photodynamic therapy in the SPECTRA trial: SPECTRA trial report No. 4.Helena M A Feenstra, Issam El Mansori, Thomas J van Rijssen
|Dec 17, 2025
Clinical outcomes of pars plana vitrectomy with endoresection in uveal melanoma primarily treated with plaque radiotherapy or proton beam therapy.Leonoor S Koetsier, Marina Marinkovic, Jaco C Bleeker
|Feb 10, 2021
Long-term follow-up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser.Thomas J van Rijssen, Elon H C van Dijk, Paula Scholz
|Aug 25, 2018
Correlation between redefined optical coherence tomography parameters and best-corrected visual acuity in non-resolving central serous chorioretinopathy treated with half-dose photodynamic therapy.Thomas J van Rijssen, Danial Mohabati, Greet Dijkman
Pageof 1
